Featured Publication
Abstract
Other/Unspecified
Treatment
Implementation of Electronic Patient-Reported Outcomes for Symptom Monitoring in a Large Multisite Community Oncology Practice: Dancing the Texas Two-Step Through a Pandemic
Read MorePoster
Ovarian
Treatment
738P – Quality-adjusted time without symptom or toxicity (QA-TWiST)
Poster
Other/Unspecified
Treatment
557TiP – SGNTUC-019: Phase II basket study of tucatinib and trastuzumab
Poster
Lung
Treatment
1870TiP – Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients with solid tumors
Poster
Lung
Treatment
1689P – Adverse event management during treatment with bintrafusp alfa
Poster
Lung
Treatment
1247P – Management of infusion-related reactions (IRRs) in patients receiving amivantamab
Poster
Lung
Treatment
1218P – Patients with EGFRex20ins+ NSCLC treated with mobocertinib…
Poster
Lung
Treatment
1195P – Brigatinib (BRG) vs crizotinib (CRZ) in ALK TKI–naive ALK+ NSCLC
Poster
Other/Unspecified
1029TiP – Phase II trial of pembrolizumab (pembro) and brentuximab vedotin (BV)…
Abstract
Lung
Treatment
MA14.03 – KRAS p.G12C-mutated NSCLC Treated With Sotorasib
Abstract
Lung
Treatment
OA15.03 – Amivantamab in Non-small Cell Lung Cancer (NSCLC)
Abstract
Lung
Treatment
OA15.01 – Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients
Abstract
Lung
Treatment